APA (7th ed.) Citation

D, Y., C, I., DM, W., C, Y., P, H., KV, G., . . . LJ, E. (2021). Ganitumab and metformin plus standard neoadjuvant therapy in stage 2/3 breast cancer. NPJ breast cancer, 7(1), 131. https://doi.org/10.1038/s41523-021-00337-2

Chicago Style (17th ed.) Citation

D, Yee, et al. "Ganitumab and Metformin Plus Standard Neoadjuvant Therapy in Stage 2/3 Breast Cancer." NPJ Breast Cancer 7, no. 1 (2021): 131. https://doi.org/10.1038/s41523-021-00337-2.

MLA (9th ed.) Citation

D, Yee, et al. "Ganitumab and Metformin Plus Standard Neoadjuvant Therapy in Stage 2/3 Breast Cancer." NPJ Breast Cancer, vol. 7, no. 1, 2021, p. 131, https://doi.org/10.1038/s41523-021-00337-2.